The Institute Pasteur is a private, non-profit foundation. Its mission is to help prevent and treat diseases, mainly those of infectious origin, through research, teaching, and public health initiatives.The Institut Pasteur is a research center of international renown ideally located in the very heart of Paris. Each year the institute hosts a multitude of scientific and medical conferences and meetings as well as events on a variety of themes.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

MannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension. Based in Westlake Village, California, the company was founded in February 1991. However, its present form is a result of a 2003 merger of three companies owned by Alfred E. Mann, Pharmaceutical Discovery Corporation (PDC), the cancer vaccine developer CTL ImmunoTherapies, Inc., and its sister company Allecure Corp, which was developing a allergy vaccine technology. MannKind Corporation was named after its founder, Alfred Mann. One of the former companies, Pharmaceutical Discovery, was purchased in 2001 from Solomon Steiner; with that purchase MannKind acquired the Technosphere molecule and Medtone inhaler, upon which was developed its lead product, Afrezza (inhalable insulin).

Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines to treat patients with serious or life-threatening medical conditions. It creates multiple products on the market and a development pipeline. The company became a member of the Roche Group in 2009. As part of their merger agreement, Roche and Genentech combined their pharmaceutical operations in the United States. Genentech’s South San Francisco campus now serves as the headquarters for Roche pharmaceutical operations in the United States. Genentech’s Research and Early Development section operates as an independent center within Roche. Genentech was founded in 1976 by [Robert Swanson](https://www.crunchbase.com/person/robert-a-swanson) and [Herbert Boyer](https://www.crunchbase.com/person/herbert-w-boyer). It is headquartered in South San Francisco, C.A.

Genmab A/S operates as an international biotechnology company. The firm develops human antibody therapeutics for the treatment of cancer and other diseases. Its product pipeline include daratumumab, marketed as DARZALEX for the treatment of certain indications of multiple myeloma; teprotumumab-trbw marketed as TEPEZZA for the treatment of thyroid eye disease; and ofatumumab, marketed as Arzerra for the treatment of certain indications of chronic lymphocytic leukemia. The company was founded by Donald Lee Drakeman, Florian Schonharting, and Jan G. J. van de Winkel on June 11, 1998 and is headquartered in Copenhagen, Denmark.

Wuhan Haijili Biotechnology Co., Ltd., established on 2010-10-21, Business scope includes production,Wholesale and retail:Class of medical equipment,Class II,Three categories6840Clinical laboratory analysis instruments and in vitro diagnostic reagents;wholesale:Three categories:6801Basic Surgical Instruments;6802Microsurgical Instruments;6803Neurosurgical Instruments;6804Ophthalmic Surgical Instruments;6805ENT Surgical Instruments;6806Dental Surgical Instruments;6807Thoracic Cardiovascular Surgery Instruments;6808Abdominal Surgery Instruments;6809Uro-anorectal surgery instruments;6810Orthopedic surgery(orthopedics)Surgical Instruments;6812Surgical Instruments for Obstetrics and Gynecology;6813Family Planning Surgical Instruments;6815injection puncture device;6816burn(plastic surgery)Surgical Instruments;6820General diagnostic equipment;6821Medical electronic equipment;6822Medical Optics,Instruments and endoscopic equipment(no software,Rigid contact lens and care solution);6823Medical Ultrasonic Instruments and Related Equipment;6824Medical laser equipment;6825Medical high-frequency equipment;6826Physiotherapy and Rehabilitation Equipment;6827Chinese medicine equipment;6828Medical Magnetic Resonance Equipment;6830medicalXX-ray equipment;6831medicalXX-ray accessories and components;6832Medical high-energy ray equipment;6833Medical nuclide equipment;6834Medical Radiation Protective Products,device;6841Medical testing and basic equipment;6845Extracorporeal circulation and blood treatment equipment;6846Implantable materials and artificial organs(Hearing aids not included);6854operating room,emergency room,Consulting room equipment and appliances;6855Dental equipment and appliances;6856Ward Nursing Equipment and Appliances;6857Disinfection and sterilization equipment and utensils;6858medical cold therapy,low temperature,Refrigeration equipment and appliances;6863Dental materials;6864Medical hygiene materials and dressings;6865Medical Suture Materials and Adhesives;6866Medical polymer materials and products;6870software;6877Intervention equipment.biology,medical technology(Contains raw materials,intermediate)Research,to develop,Scientific research achievements transfer and related technology consulting and transfer services;Scientific reagents(Eliminate drugs and dangerous goods)production,Wholesale and retail;Import and export,Technology Import and Export(Does not contain goods or technologies that are prohibited or restricted from import and export by the state);General Machinery,Leasing of mechanical and electrical equipment.(Projects subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Beijing Dingcheng Peptide Source Biotechnology Co., Ltd., established on 2014-03-26, Business scope includes biological,Pharmaceutical technology development,technology transfer,technical consulting,Technical Services;Sales of biological reagents(Free of Hazardous Chemicals,medicine).(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Manufactures and sells pharmaceuticals

Therakos, Inc. develops immune cell therapies delivered through extracorporeal photopheresis. The firm’s engineers, clinicians and biological researchers have been driven to discover new technologies and therapeutic applications that empower the immune response and improve patient outcomes. It supports clinicians by providing products and training to enhance the treatment of cutaneous T-cell lymphoma (CTCL) and by pursuing additional approved indications for autologous immune cell therapy. The company was founded in 1984 and is headquartered in West Chester, PA.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

INHA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION provides practical help for improving the technology of an industrial field.

GenId is an electronic engineering company that delivers cost-effective and customized IT solutions.

The Pasteur Institute of Lille (French: Institut Pasteur de Lille, Pasteur-Lille, IPL) is a research centre and member of the Pasteur Institute network. It includes 14 research units and 1,150 employees including 626 researchers located in Lille, France. There are also 300 employees located outside the Pasteur site. Its revenues are above €70 million. Several neuroscience start-up companies have emerged from the Pasteur Institute of Lille.

Chengdu Yianbo Biotechnology Co., Ltd., established on 2016-07-21, Business scope includes biological antibody related technology research and development,Antibody Screening,Antibody Drug Development,Technical consultation related to immunoassay,R&D of immunotherapy technology,Biopharmaceutical Technology R&D,health and beauty,Anti-aging Technology Consulting,Technical Services,technology transfer;Sales:Medical instrumentation,medical software,medical instruments(Did not obtain the relevant administrative license(approval),Do not carry out business activities),biopharmaceuticals(Did not obtain the relevant administrative license(approval),Do not carry out business activities),chemical reagent(Free of Hazardous Chemicals),laboratory equipment,Glass product,plastic products;Biological industry goods and technology import and export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Guangzhou Daidai Pharmaceutical Technology Co., Ltd., established on 2013-05-20, Business scope includes medical research and experimental development;drug development;Retailing of cosmetics and hygiene products;Wholesale of cosmetics and hygiene products;Nutrition and Health Consulting Services;Health Sciences Program Research,to develop;Acupuncture Medicine Research;Manufacturing of dental equipment and appliances;

Medarex is a biopharmaceutical company focused on the discovery, development and potential commercialization of fully human antibody-based therapeutics to treat life-threatening and debilitating diseases, including cancer, inflammation, autoimmune disorders and infectious diseases. Medarex applies its UltiMAb® technology and product development and clinical manufacturing experience to generate, support and potentially commercialize a broad range of fully human antibody product candidates for itself and its partners.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Kenilworth, NJ.